Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Prices of Medical Devices Are Secondary Matters: Mr Rozynski of AdvaMed
November 5, 2001
- Mitsubishi Chemical Safety Institute Establishes Alliance with PRXL
November 5, 2001
- MEDICAL DEVICE NEWS IN BRIEF
November 5, 2001
- NBI, Daiichi Provide Results of Immediate PMS for Mobic
November 5, 2001
- WORLD NEWS IN BRIEF
November 5, 2001
- Toyobo, Nichirei to Form Contract Mfg. Firm of Antibody Drugs
November 5, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
November 5, 2001
- Use of Corticosteroid Is Low: GSK Survey Results
November 5, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
November 5, 2001
- REGULATORY NEWS IN BRIEF
November 5, 2001
- JABEX Calls For Policy to Make Japan Bioindustry-based Nation
November 5, 2001
- JPA Opposes Healthcare Cost Ceiling System
November 5, 2001
- Healthcare Services Incompatible with Market Economy: JMA Seminar
November 5, 2001
- WORLD NEWS IN BRIEF
October 29, 2001
- Overseas Business Strategy of Domestic Firms Focused on:PMSRL Seminar
October 29, 2001
- Chugai Licenses in Polyglutamate Paclitaxel from CTI Technologies
October 29, 2001
- Meiji Seika to Codevelop Antibiotics with Kosan Biosciences in US
October 29, 2001
- Kowa, Novartis to Comarket Hypadil Kowa Ophthalmic Solution
October 29, 2001
- 60th Annual Meeting of the Japanese Cancer Association
October 29, 2001
- Companies' Interest in Pharmacoeconomics Data Has Declined
October 29, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…